Oppenheimer Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-210	Closed	-$335K	–	1166
2018 Q1	$335K	Buy	+210	New	+$335K	0.01%	901
2017 Q4	–	Sell	-359	Closed	-$129K	–	1339
2017 Q3	$129K	Buy	+359	New	+$129K	﹤0.01%	1145